Whitepaper

New material engineered can repair severed nerves

Drug Target Review Drug Target Review
18 Oct 2023 4 min read

Login or Register

After logging in, you can access the full content
Researchers designed the first magnetoelectric material that precisely stimulates neurons to treat nerve damage.

Scientists have long seen the therapeutic potential of using magnetoelectrics, materials that can turn magnetic fields into electric fields, to treat neurological disorders or nerve damage by stimulating neural tissue as non-invasively as possible. However, neurons have difficulty responding to the shape and frequency of the electric signal resulting from this conversion.

Published in Nature Materials, Rice University neuroengineer Dr Jacob Robinson and his team designed the first magnetoelectric material that solves the issue and also performs the magnetic-to-electric conversion 120 times faster than similar materials. The researchers demonstrated the material can be used to precisely stimulate neurons remotely and to repair the gap in a broken sciatic nerve in a rat model.

Robinson said that the material’s qualities and performance may have a significant impact on neurostimulation treatments, resulting in less invasive procedures. Tiny amounts of the material could be injected at the desired site instead of implanting a neurostimulation device. Magnetoelectrics’ can be applied to computing, sensing, electronics and other fields, so the research provides a framework for advanced materials design that may push innovation more widely.

Joshua Chen, Rice doctoral alumnus and lead author, said: “We asked, ‘Can we create a material that can be like dust or is so small that by placing just a sprinkle of it inside the body you’d be able to stimulate the brain or nervous system?” He continued: “With that question in mind, we thought that magnetoelectric materials were ideal candidates for use in neurostimulation. They respond to magnetic fields, which easily penetrate into the body, and convert them into electric fields ⎯ a language our nervous system already uses to relay information.”

The researchers began with a magnetoelectric material made from a piezoelectric layer of lead zirconium titanate sandwiched between two magnetorestrictive layers of metallic glass alloys, ‘Metglas’, which can be quickly magnetized and demagnetised.

Dr Gauri Bhave, a former researcher at  the Robinson lab who currently works in technology transfer for Baylor College of Medicine, explained that the magnetorestrictive element vibrates with the application of a magnetic field.

“This vibration means it basically changes its shape,” Bhave stated. “The piezoelectric material is something that, when it changes its shape, creates electricity. So when those two are combined, the conversion that you’re getting is that the magnetic field you’re applying from the outside of the body turns into an electric field.”

Therefore, a new material was engineered that generated electric signals for cell response, made from layered platinum, hafnium oxide and zinc oxide which was placed on top of the original magnetoelectric field.

“A lot of work went into making this very thin layer of less than 200 nanometres that gives us the really special properties,” Robinson said.

“A lot of work went into making this very thin layer of less than 200 nanometres that gives us the really special properties,” Robinson said.

“This reduced the size of the entire device so that in the future it could be injectable,” Bhave added.

The scientists used this material to stimulate peripheral nerves in rats and demonstrated its potential for neuroprosthetic use, as it could restore function in a severed nerve.

 

“We can use this metamaterial to bridge the gap in a broken nerve and restore fast electric signal speeds,” Chen said.

“We can use this metamaterial to bridge the gap in a broken nerve and restore fast electric signal speeds,” Chen said.

Robinson drew on his doctoral work in photonics for inspiration in manufacturing the new material and said he finds it “really exciting that we can now design devices or systems using materials that have never existed before rather than being confined to ones in nature.”

Related Whitepapers

Central Nervous System (CNS)
Drug Targets
Enzymes
Mitochondria
Neuroprotection
Neurosciences
Pharmacology
Translational Science
+7
06 November 2025

BVRA enzyme may slow down Alzheimer’s progression

New research from Johns Hopkins Medicine reveals that the enzyme BVRA protects brain cells from oxidative stress, allowing for potential new methods f...

Drug Target Review Drug Target Review
Nov 6, 2025 • 1 min read
Assays
Bioengineering
Biomarkers
CRISPR
Disease Research
Neurosciences
RNAs
Translational Science
+7
04 November 2025

New blood test detects Alzheimer’s years before symptoms

Scientists have developed two rapid and affordable blood tests that can detect early markers of Alzheimer’s disease – potentially decades before sympt...

Drug Target Review Drug Target Review
Nov 4, 2025 • 1 min read
Central Nervous System (CNS)
CRISPR
Epigenetics
Molecular Biology
Neurons
Neurosciences
Therapeutics
Translational Science
+7
30 October 2025

CRISPR epigenetic ‘switch’ provides new way to control memory

For the first time, researchers have demonstrated that flipping an epigenetic ‘switch’ in memory cells can directly control whether a memory is expres...

Carrie Haslam Carrie Haslam
Oct 30, 2025 • 1 min read
Animal Models
Central Nervous System (CNS)
Disease Research
Drug Discovery
Drug Discovery Processes
In Vivo
Molecular Targets
Neuroprotection
Neuroprotective compounds
Neurosciences
Translational Science
+10
29 October 2025

Overactive neurons linked to schizophrenia-like behaviour

Scientists have identified an overactive brain cell type linked to schizophrenia-like symptoms in mice – a discovery that could lead to new, targeted ...

Carrie Haslam Carrie Haslam
Oct 29, 2025 • 1 min read
Central Nervous System (CNS)
Clinical Trials
Disease Research
Drug Discovery
Drug Discovery Processes
Neurosciences
Positron emission tomography (PET)
Screening
Translational Science
+8
28 October 2025

New PET tracer could lead to better ALS and Alzheimer’s diagnosis

Explore the advancements in Alzheimer's diagnosis with ACI-19626, a new PET tracer for precise neurodegenerative imaging....

Carrie Haslam Carrie Haslam
Oct 28, 2025 • 1 min read
Drug Targets
Molecular Biology
Neurons
Neurosciences
Therapeutics
Translational Science
+5
16 October 2025

Improving brain resilience: Rab proteins and future treatments

New research has discovered how Rab proteins control the delivery of critical supplies to strengthen neural connections, providing researchers with im...

Carrie Haslam Carrie Haslam
Oct 16, 2025 • 3 min read
Cell Cultures
Central Nervous System (CNS)
Disease Research
Drug Discovery
Drug Discovery Processes
Epigenetics
In Vitro
Neurons
Neuroprotection
Neurosciences
Stem Cells
Translational Science
+11
13 October 2025

DARG cells may drive neurodegeneration in progressive MS

Scientists have discovered a rare type of brain cell that appears to drive the chronic inflammation seen in progressive multiple sclerosis – which cou...

Drug Target Review Drug Target Review
Oct 13, 2025 • 4 min read